RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury

<div>Cleaved caspase-9 pneumocyte expression in lung tissues. The RC-Post group exhibited a significant overexpression of cleaved caspase-9 (<i>P</i> &lt; 0.013) compared to the other groups. Data are presented as the median ± standard error of the median.</div>

BioMed Research International

fig4

Figure 4

Figure 4: RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury 

Figure 4 | RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury 